126 related articles for article (PubMed ID: 1824776)
1. Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses.
Burns JM; Scott JM; Carvalho EM; Russo DM; March CJ; Van Ness KP; Reed SG
J Immunol; 1991 Jan; 146(2):742-8. PubMed ID: 1824776
[TBL] [Abstract][Full Text] [Related]
2. The PSA-2 glycoprotein complex of Leishmania major is a glycosylphosphatidylinositol-linked promastigote surface antigen.
Murray PJ; Spithill TW; Handman E
J Immunol; 1989 Dec; 143(12):4221-6. PubMed ID: 2592773
[TBL] [Abstract][Full Text] [Related]
3. Antigen-reactive gamma delta T cells in human leishmaniasis.
Russo DM; Armitage RJ; Barral-Netto M; Barral A; Grabstein KH; Reed SG
J Immunol; 1993 Oct; 151(7):3712-8. PubMed ID: 8376802
[TBL] [Abstract][Full Text] [Related]
4. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.
Scott P; Caspar P; Sher A
J Immunol; 1990 Feb; 144(3):1075-9. PubMed ID: 2295814
[TBL] [Abstract][Full Text] [Related]
5. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein.
Pan AA; McMahon-Pratt D
J Immunol; 1989 Aug; 143(3):1001-8. PubMed ID: 2501384
[TBL] [Abstract][Full Text] [Related]
6. Isolation, purification, characterization and antigenic evaluation of GPI-anchored membrane proteins from Leishmania (Viannia) braziliensis.
Rojas A; García-Lugo P; Crisante G; Añez-Rojas N; Añez N
Acta Trop; 2008 Feb; 105(2):139-44. PubMed ID: 18054342
[TBL] [Abstract][Full Text] [Related]
7. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
[TBL] [Abstract][Full Text] [Related]
8. Mapping human T cell epitopes in leishmania gp63. Identification of cross-reactive and species-specific epitopes.
Russo DM; Jardim A; Carvalho EM; Sleath PR; Armitage RJ; Olafson RW; Reed SG
J Immunol; 1993 Feb; 150(3):932-9. PubMed ID: 7678627
[TBL] [Abstract][Full Text] [Related]
9. Structural analysis of glycosyl-phosphatidylinositol antigens of Leishmania major.
Rosen G; Påhlsson P; Londner MV; Westerman ME; Nilsson B
J Biol Chem; 1989 Jun; 264(18):10457-63. PubMed ID: 2525125
[TBL] [Abstract][Full Text] [Related]
10. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
Prina E; Lang T; Glaichenhaus N; Antoine JC
J Immunol; 1996 Jun; 156(11):4318-27. PubMed ID: 8666803
[TBL] [Abstract][Full Text] [Related]
11. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies specific for the amastigote stage of Leishmania pifanoi. I. Characterization of antigens associated with stage- and species-specific determinants.
Pan AA; McMahon-Pratt D
J Immunol; 1988 Apr; 140(7):2406-14. PubMed ID: 2450920
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies specific for Leishmania tropica. I. Characterization of antigens associated with stage- and species-specific determinants.
Jaffe CL; McMahon-Pratt D
J Immunol; 1983 Oct; 131(4):1987-93. PubMed ID: 6194223
[TBL] [Abstract][Full Text] [Related]
14. Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes.
Sacks DL; Hieny S; Sher A
J Immunol; 1985 Jul; 135(1):564-9. PubMed ID: 2582050
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins.
Bonfa E; Viana VS; Barreto AC; Yoshinari NH; Cossermelli W
J Immunol; 1993 May; 150(9):3917-23. PubMed ID: 8473740
[TBL] [Abstract][Full Text] [Related]
16. Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression.
Akuffo HO; Fehniger TE; Britton S
J Immunol; 1988 Oct; 141(7):2461-6. PubMed ID: 3171177
[TBL] [Abstract][Full Text] [Related]
17. Leishmania major: molecular cloning, sequencing, and expression of the heat shock protein 60 gene reveals unique carboxy terminal peptide sequences.
Rey-Ladino JA; Joshi PB; Singh B; Gupta R; Reiner NE
Exp Parasitol; 1997 Mar; 85(3):249-63. PubMed ID: 9085922
[TBL] [Abstract][Full Text] [Related]
18. Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis.
Ajdary S; Riazi-Rad F; Alimohammadian MH; Pakzad SR
J Infect; 2009 Aug; 59(2):139-43. PubMed ID: 19560211
[TBL] [Abstract][Full Text] [Related]
19. Identification and gene cloning of a new phosphatidylinositol-linked antigen expressed on mature lymphocytes. Down-regulation by lymphocyte activation.
Kubota H; Okazaki H; Onuma M; Kano S; Hattori M; Minato N
J Immunol; 1990 Dec; 145(11):3924-31. PubMed ID: 2147207
[TBL] [Abstract][Full Text] [Related]
20. A common major surface antigen on amastigotes and promastigotes of Leishmania species.
Colomer-Gould V; Glvao Quintao L; Keithly J; Nogueira N
J Exp Med; 1985 Sep; 162(3):902-16. PubMed ID: 4031788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
